← Open Payments lookup

SUSAN GORSCHBOTH: Open Payments

NPI 1639722036 · ABINGDON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,042 in 64 payments from 16 companies in 2025. Trend: 2023 $632 · 2024 $1,238 · 2025 $1,042

Food & beverage: $1,042
CompanyPaymentsAmount
Novo Nordisk Inc15$188
ABBVIE INC.13$160
Astellas Pharma US Inc7$145
Lilly USA, LLC8$136
Exact Sciences Corporation3$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$65
Amgen Inc.3$55
PFIZER INC.2$44
Bayer Healthcare Pharmaceuticals Inc.2$40
GlaxoSmithKline, LLC.2$33

Products named: Veozah, Ozempic, UBRELVY, VRAYLAR, The Cologuard Plus Collection Kit, MOUNJARO, XIFAXAN, OTEZLA.

Industry payments across MD — which companies pay providers there.